The androgen receptor as a therapeutic target for myelin repair in demyelinating diseases

Expert Review of Endocrinology and Metabolism

Volumn 9, Issue 1, 2014, Pages 5-7

  Ghandour, Said ^c   Voskuhl, Rhonda ^a   Schumacher, Michael ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

7 methyl 19 nortestosterone; androgen receptor; beta catenin; multiple sclerosis; myelin; progesterone; remyelination; testosterone; thyroid hormones; Wnt

Indexed keywords

ANDROGEN RECEPTOR; BETA CATENIN; ESTRADIOL; GESTAGEN; MYELIN; RETINOID X RECEPTOR; SONIC HEDGEHOG PROTEIN; TESTOSTERONE; THYROID HORMONE; WNT PROTEIN;

ANDROGEN THERAPY; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN LEVEL; CASTRATED MALE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COGNITION; CONTRACEPTION; CORPUS CALLOSUM; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; DEMYELINATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; INTRACELLULAR SIGNALING; LONG TERM CARE; MICROGLIA; MULTIPLE SCLEROSIS; MYELIN SHEATH; MYELINATED NERVE; MYELINATION; NERVE FIBER; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; REMYELINIZATION; REPRODUCTION; REVIEW; RIGHT HEMISPHERE; SEX DIFFERENCE; SYNAPTIC TRANSMISSION; T LYMPHOCYTE; WHITE MATTER;

EID: 84893106165     PISSN: 17446651     EISSN: 17448417     Source Type: Journal    
DOI: 10.1586/17446651.2014.861740     Document Type: Review

References (24)

1. Kieseier BC, Stuve O. A critical appraisal of treatment decisions in multiple sclerosis-old versus new. Nat. Rev. Neurol. 7, 255-262 (2011
2. Harsan LA, Steibel J, Zaremba A et al. Recovery from chronic demyelination by thyroid hormone therapy: Myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging. J. Neurosci. 28, 14189-14201 (2008
3. Huang JK, Jarjour AA, Nait OB et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat. Neurosci. 14, 45-53 (2011
4. Hussain R, el-Etr M, Gaci O et al. Progesterone and nestorone facilitate axon remyelination: A role for progesterone receptors. Endocrinology 152, 3820-3831 (2011
5. Ferent J, Zimmer C, Durbec P, Ruat M, Traiffort E. Sonic Hedgehog signaling is a positive oligodendrocyte regulator during demyelination. J. Neurosci. 33, 1759-1772 (2013
6. Fancy SP, Baranzini SE, Zhao C et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 23, 1571-1585 (2009
7. Tawk M, Makoukji J, Belle M et al. Wnt/ beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis. J. Neurosci. 31, 3729-3742 (2011
8. Doncarlos LL, Sarkey S, Lorenz B et al. Novel cellular phenotypes and subcellular sites for androgen action in the forebrain. Neuroscience 138, 801-807 (2006
9. Finley SK, Kritzer MF. Immunoreactivity for intracellular androgen receptors in identified subpopulations of neurons, astrocytes and oligodendrocytes in primate prefrontal cortex. J. Neurobiol. 40, 446-457 (1999
10. Fargo KN, Foecking EM, Jones KJ, Sengelaub DR. Neuroprotective actions of androgens on motoneurons. Front. Neuroendocrinol. 30, 130-141 (2009
11. Liva SM, Voskuhl RR. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J. Immunol. 167, 2060-2067 (2001
12. Palaszynski KM, Loo KK, Ashouri JF, Liu HB, Voskuhl RR. Androgens are protective in experimental autoimmune encephalomyelitis: Implications for multiple sclerosis. J. Neuroimmunol. 146, 144-152 (2004
13. Dalal M, Kim S, Voskuhl RR. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159, 3-6 (1997
14. Matejuk A, Hopke C, Vandenbark AA, Hurn PD, Offner H. Middle-age male mice have increased severity of experimental autoimmune encephalomyelitis and are unresponsive to testosterone therapy. J. Immunol. 174, 2387-2395 (2005
15. Sicotte NL, Giesser BS, Tandon V et al. Testosterone treatment in multiple sclerosis: A pilot study. Arch. Neurol. 64, 683-688 (2007
16. Gold SM, Chalifoux S, Giesser BS, Voskuhl RR. Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone. J. Neuroinflammation 5, 32 (2008
17. Ziehn MO, Avedisian AA, Dervin SM, Umeda EA, O'Dell TJ, Voskuhl RR. Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease. J. Neurosci. 32, 12312-12324 (2012
18. Cerghet M, Skoff RP, Bessert D, Zhang Z, Mullins C, Ghandour MS. Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents. J. Neurosci. 26, 1439-1447 (2006
19. Perrin JS, Herve PY, Leonard G et al. Growth of white matter in the adolescent brain: Role of testosterone and androgen receptor. J. Neurosci. 28, 9519-9524 (2008
20. Hussain R, Ghoumari AM, Bielecki B et al. The neural androgen receptor: A therapeutic target for myelin repair in chronic demyelination. Brain 136, 132-146 (2013
21. Nieschlag E, Kumar N, Sitruk-Ware R. 7alpha-Methyl-19-nortestosterone (MENT (R)): The Population Council's contribution to research on male contraception and treatment of hypogonadism. Contraception 87, 288-295 (2013
22. Wei T, Lightman SL. The neuroendocrine axis in patients with multiple sclerosis. Brain 120, 1067-1076 (1997
23. Bove R, Musallam A, Healy BC et al. Testosterone and disease severity in men with early relapsing onset multiple sclerosis. Am. Acad. Neurol. Abstracts (2013
24. Haring R, Hannemann A, John U et al. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry. J. Clin. Endocrinol. Metab. 97, 408-415 (2012